-
|
Here is the
citation and the abstract for the revised Beers
criteria...
Arch
Intern Med. 2003 Dec 8-22;163(22):2716-24. |
|
-
Updating the Beers
criteria for potentially inappropriate medication use in older adults:
results of a US consensus panel of experts.
Fick
DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers
MH.
Department of Medicine, Center for Health Care
Improvement, Medical College of Georgia, Augusta 30912, USA.
[EMAIL PROTECTED]
BACKGROUND: Medication toxic effects and
drug-related problems can have profound medical and safety consequences
for older adults and economically affect the health care system. The
purpose of this initiative was to revise and update the Beers criteria
for potentially inappropriate medication use in adults 65 years and
older in the United States. METHODS: This study used a modified Delphi
method, a set of procedures and methods for formulating a group judgment
for a subject matter in which precise information is lacking. The
criteria reviewed covered 2 types of statements: (1) medications or
medication classes that should generally be avoided in persons 65 years
or older because they are either ineffective or they pose unnecessarily
high risk for older persons and a safer alternative is available and (2)
medications that should not be used in older persons known to have
specific medical conditions. RESULTS: This study identified 48
individual medications or classes of medications to avoid in older
adults and their potential concerns and 20 diseases/conditions and
medications to be avoided in older adults with these conditions. Of
these potentially inappropriate drugs, 66 were considered by the panel
to have adverse outcomes of high severity. CONCLUSIONS: This study is an
important update of previously established criteria that have been
widely used and cited. The application of the Beers criteria and other
tools for identifying potentially inappropriate medication use will
continue to enable providers to plan interventions for decreasing both
drug-related costs and overall costs and thus minimize drug-related
problems.
PMID: 14662625 [PubMed - indexed for MEDLINE]
| Summary Brief Abstract Citation ASN.1
MEDLINE XML UI List
LinkOut Related Articles Cited in Books Domain Links 3D Domain Links GEO DataSet Links Gene Links Genome Links GEO Links Nucleotide Links OMIM Links PMC
Links Cited in PMC
PopSet Links Protein Links SNP Links Structure Links UniSTS Links
Show: 5 10 20 50 100
200 500
Sort Author Journal Pub Date
Text File Clipboard E-mail Order
|
|
| |
|
|
| |
|
Jan 29
2004
15:06:34 |
STATEMENT OF CONFIDENTIALITY:
The information contained in this electronic message and any attachments to this message are intended for the exclusive use of the addressee(s) and may contain confidential or privileged information. If you are not the intended recipient, please notify Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. immediately at either (617) 542-6000 or at [EMAIL PROTECTED], and destroy all copies of this message and any attachments.